Despite the contradictory result in the expression trends, current p40-NRF2 results support our previous observation, namely, that the NRF2 expression favours worse disease-specific survival, and the role of NRF2 in melanoma carcinogenesis seems to be rather consistent with NRF1. This evidence concerns the gene NRF1 and melanoma.